These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28358597)

  • 1. Common genetic polymorphisms of adenosine A2A receptor do not influence response to regadenoson.
    Berlacher M; Mastouri R; Philips S; Skaar TC; Kreutz RP
    Pharmacogenomics; 2017 Apr; 18(6):523-529. PubMed ID: 28358597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
    Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily Caffeine Consumption Is Associated with Decreased Incidence of Symptoms and Hemodynamic Changes During Pharmacologic Stress with Regadenoson.
    Posch MI; Kay MD; Harhash AA; Huang JJ; Krupinski EA; Abidov A; McMillan NA; Kuo PH
    J Nucl Med Technol; 2020 Mar; 48(1):73-76. PubMed ID: 31604901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson.
    Noel CV; Krishnamurthy R; Moffett B; Krishnamurthy R
    Pediatr Radiol; 2017 Mar; 47(3):280-289. PubMed ID: 28035425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Stress Perfusion MRI: Experience in Pediatric and Young-Adult Patients Following Arterial Switch Operation Utilizing Regadenoson.
    Noel CV; Krishnamurthy R; Masand P; Moffett B; Schlingmann T; Cheong BY; Krishnamurthy R
    Pediatr Cardiol; 2018 Aug; 39(6):1249-1257. PubMed ID: 29748700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect evidence of sympathetic stimulation by regadenoson.
    Farris GR; Hage FG; Kumar V; Iskandrian AE
    J Nucl Cardiol; 2019 Apr; 26(2):684-687. PubMed ID: 29948894
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of body mass index and type of low-level exercise on the side effect profile of regadenoson.
    Salgado-Garcia C; Jimenez-Heffernan A; Lopez-Martin J; Molina-Mora M; Aroui T; Sanchez de Mora E; Ramos-Font C; Rivera de Los Santos F; Ruiz-Frutos C
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1906-1914. PubMed ID: 28547175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the A2a receptor agonist, regadenoson, in modulating hepatic artery flow in the porcine small-for-size liver graft.
    Zhu X; Shiba H; Fung JJ; Wang LF; Arakawa Y; Irefin S; Demetris AJ; Kelly DM
    J Surg Res; 2012 May; 174(1):e37-45. PubMed ID: 22225980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve.
    Arumugham P; Figueredo VM; Patel PB; Morris DL
    EuroIntervention; 2013 Feb; 8(10):1166-71. PubMed ID: 23164748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An example of the clinical selectivity of regadenoson for the A2a adenosine receptor.
    Miyamoto MI; Clarke KA; Thomas GS; Belardinelli L
    Am Heart Hosp J; 2009; 7(2):E118-21. PubMed ID: 20354957
    [No Abstract]   [Full Text] [Related]  

  • 12. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.
    Palani G; Ananthasubramaniam K
    Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of regadenoson for measurement of fractional flow reserve.
    Prasad A; Zareh M; Doherty R; Gopal A; Vora H; Somma K; Mehra A; Clavijo LC; Matthews RV; Shavelle DM
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):369-74. PubMed ID: 23765847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of regadenoson for myocardial perfusion imaging - first Danish experience.
    Pape M; Zacho HD; Aarøe J; Eggert Jensen S; Petersen LJ
    Scand Cardiovasc J; 2016 Jun; 50(3):180-6. PubMed ID: 26956081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.
    Lieu HD; Shryock JC; von Mering GO; Gordi T; Blackburn B; Olmsted AW; Belardinelli L; Kerensky RA
    J Nucl Cardiol; 2007 Jul; 14(4):514-20. PubMed ID: 17679059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in pharmacologic stress agents: focus on regadenoson.
    Johnson SG; Peters S
    J Nucl Med Technol; 2010 Sep; 38(3):163-71. PubMed ID: 20724531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.
    Goudarzi B; Fukushima K; Bravo P; Merrill J; Bengel FM
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1908-16. PubMed ID: 21656246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.
    Cerqueira MD; Nguyen P; Staehr P; Underwood SR; Iskandrian AE;
    JACC Cardiovasc Imaging; 2008 May; 1(3):307-16. PubMed ID: 19356442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPD1 polymorphism and response to regadenoson.
    Saab R; Zouk AN; Mastouri R; Skaar TC; Philips S; Kreutz RP
    Pharmacogenomics; 2015 Nov; 16(16):1807-15. PubMed ID: 26554440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
    Friedman M; Spalding J; Kothari S; Wu Y; Gatt E; Boulanger L
    J Med Econ; 2013; 16(4):449-60. PubMed ID: 23363331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.